Senile plaques are abnormal clusters of protein fragments known as beta-amyloid that accumulate between nerve cells in the brains of individuals with Alzheimer's disease. These plaques are one of the hallmark features of the disease and are believed to disrupt communication between neurons, contributing to cognitive decline and memory loss. Over time, the accumulation of these plaques can lead to inflammation and damage to nearby cells, further impairing brain function.
Researchers believe that understanding how and why these plaques form is crucial to developing effective treatments for Alzheimer's disease and related dementias. Strategies to reduce plaque formation or enhance the brain's ability to clear these proteins are areas of active investigation in the quest to slow or halt the progression of Alzheimer's disease. Thus, senile plaques not only serve as a diagnostic marker but also represent a focal point for therapeutic interventions aimed at combating this devastating neurodegenerative disorder.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States